Literature DB >> 34027744

Assessing the Quality of SK&A's Office-Based Physician Database for Identifying Oncologists.

Samuel Valdez1,2, Mireille Jacobson1.   

Abstract

Health services research increasingly uses commercial databases that capture provider practice characteristics. Little is known about how these data sets compare along other dimensions with publicly available data. We assess the quality of one of the most commonly used commercial databases, SK&A's office-based physician database, for capturing oncologists who bill the Medicare fee-for-service program. Using 2017 data, we find that nearly 74% of the oncologists in Medicare claims can be found in the SK&A data. Weighted by patients, service volume, or spending, match rates increase to 77%, 96%, and 92%, respectively. Matched oncologists have a high concordance (above 95%) on subspecialty as well as contact information other than street address. Oncologists who appear only in Medicare tend to have low service volumes and spending relative to those who are matched while over half of oncologists who appear only in SK&A have a pediatric subspecialty.

Entities:  

Keywords:  oncologists; outpatient physician database; validation

Mesh:

Year:  2021        PMID: 34027744      PMCID: PMC9177237          DOI: 10.1177/10775587211013628

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   2.971


  19 in total

1.  The Results Are Only as Good as the Sample: Assessing Three National Physician Sampling Frames.

Authors:  Catherine M DesRoches; Kirsten A Barrett; Bonnie E Harvey; Rachel Kogan; James D Reschovsky; Bruce E Landon; Lawrence P Casalino; Stephen M Shortell; Eugene C Rich
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

2.  Primary Care Physician Networks In Medicare Advantage.

Authors:  Yevgeniy Feyman; José F Figueroa; Daniel E Polsky; Michael Adelberg; Austin Frakt
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

3.  Evaluating The Role Of Payment Policy In Driving Vertical Integration In The Oncology Market.

Authors:  Abby Alpert; Helen Hsi; Mireille Jacobson
Journal:  Health Aff (Millwood)       Date:  2017-04-01       Impact factor: 6.301

4.  Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?

Authors:  Michael M McNeil; Rongxia Li; Susanne Pickering; Theresa M Real; Philip J Smith; Michael R Pemberton
Journal:  Vaccine       Date:  2013-04-16       Impact factor: 3.641

5.  Using the National Provider Identifier for health care workforce evaluation.

Authors:  Andrew B Bindman
Journal:  Medicare Medicaid Res Rev       Date:  2013-07-30

6.  How vertical integration affects the quantity and cost of care for Medicare beneficiaries.

Authors:  Thomas G Koch; Brett W Wendling; Nathan E Wilson
Journal:  J Health Econ       Date:  2017-01-17       Impact factor: 3.883

7.  The effect of hospital acquisitions of physician practices on prices and spending.

Authors:  Cory Capps; David Dranove; Christopher Ody
Journal:  J Health Econ       Date:  2018-04-22       Impact factor: 3.883

8.  Primary care access for new patients on the eve of health care reform.

Authors:  Karin V Rhodes; Genevieve M Kenney; Ari B Friedman; Brendan Saloner; Charlotte C Lawson; David Chearo; Douglas Wissoker; Daniel Polsky
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

9.  Rural And Nonrural Primary Care Physician Practices Increasingly Rely On Nurse Practitioners.

Authors:  Hilary Barnes; Michael R Richards; Matthew D McHugh; Grant Martsolf
Journal:  Health Aff (Millwood)       Date:  2018-06       Impact factor: 6.301

10.  Vertical Integration and Physician Practice Labor Composition.

Authors:  Hilary Barnes; Grant R Martsolf; Matthew D McHugh; Michael R Richards
Journal:  Med Care Res Rev       Date:  2020-11-13       Impact factor: 3.929

View more
  1 in total

1.  Do Medicare's Facility Fees Incentivize Hospitals to Vertically Integrate with Oncologists?

Authors:  Samuel Valdez
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.